학술논문

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, July 2019, 20(7):984-997)
Subject
Language
English
ISSN
14745488
14702045